Package 45802-087-65

Brand: alogliptin

Generic: alogliptin
NDC Package

Package Facts

Identity

Package NDC 45802-087-65
Digits Only 4580208765
Product NDC 45802-087
Description

30 TABLET, FILM COATED in 1 BOTTLE (45802-087-65)

Marketing

Marketing Status
Marketed Since 2016-04-08
Brand alogliptin
Generic alogliptin
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "1287590b-abdf-470b-a611-dfb9bc93692a", "openfda": {"upc": ["0345802087652", "0345802103659", "0345802150653"], "unii": ["EEN99869SC"], "rxcui": ["1368006", "1368018", "1368034"], "spl_set_id": ["b25f155a-1259-47c2-aa3b-7c1356e4c7f6"], "manufacturer_name": ["Padagis Israel Pharmaceuticals Ltd"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, FILM COATED in 1 BOTTLE (45802-087-65)", "package_ndc": "45802-087-65", "marketing_start_date": "20160408"}], "brand_name": "Alogliptin", "product_id": "45802-087_1287590b-abdf-470b-a611-dfb9bc93692a", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Dipeptidyl Peptidase 4 Inhibitor [EPC]", "Dipeptidyl Peptidase 4 Inhibitors [MoA]"], "product_ndc": "45802-087", "generic_name": "Alogliptin", "labeler_name": "Padagis Israel Pharmaceuticals Ltd", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Alogliptin", "active_ingredients": [{"name": "ALOGLIPTIN BENZOATE", "strength": "6.25 mg/1"}], "application_number": "NDA022271", "marketing_category": "NDA AUTHORIZED GENERIC", "marketing_start_date": "20160408", "listing_expiration_date": "20261231"}